Omega-3 and Sleep: Can Fish Oil Help You Rest Better?
Omega-3 fatty acids are usually discussed in the context of heart health, inflammation and joint comfort. In recent years researchers have started asking a different question: could EPA and DHA influence how well we sleep? For athletes, whose recovery depends heavily on sleep, the answer matters. Our editorial team reviewed what the studies actually show.
Why sleep is a recovery tool
Sleep is when much of the body's repair work happens. Growth hormone secretion peaks in deep sleep, glycogen stores are replenished, and the brain consolidates the motor learning gained in practice. Chronic sleep restriction is associated with slower reaction times, poorer mood, reduced endurance and a higher injury risk.
A review by Halson (2014) highlighted that elite athletes often sleep less and worse than they should, due to early training sessions, travel, late competitions and pre-event anxiety. Nutrition is one of several levers that can influence sleep, alongside schedules, light exposure and caffeine timing.
The American Academy of Sleep Medicine recommends that adults get at least seven hours of sleep per night. Many sports scientists suggest that athletes under heavy training loads may benefit from more, including naps.
Against this background, supplements that could improve sleep quality naturally attract attention. Omega-3s are interesting because they are already widely used for other reasons, so any sleep benefit would be a bonus rather than the main motivation.
How omega-3s might affect sleep
DHA is a major structural component of brain cell membranes, including in regions involved in sleep regulation. Animal studies suggest that DHA deficiency can disturb melatonin production in the pineal gland and alter the normal rhythm of the sleep-wake cycle.
EPA and DHA are precursors of signaling molecules, including prostaglandins and resolvins, that influence inflammation. Prostaglandin D2, derived from omega-6 fatty acids but influenced by fatty acid balance, is one of the most potent sleep-promoting substances known in the brain. Changing membrane fatty acid composition may therefore indirectly affect sleep signaling.
Omega-3s also influence the autonomic nervous system. Higher intakes have been associated with improved heart rate variability, a marker of parasympathetic activity that tends to be higher during restful sleep.
These pathways are plausible, but plausibility is not proof. The key question is whether supplementing omega-3 in humans leads to measurable improvements in sleep.
What human studies have found
One of the more cited studies is the DOLAB trial by Montgomery and colleagues (2014), which gave DHA supplements to UK children with below-average reading skills. A subgroup that underwent actigraphy showed fewer night wakings and longer total sleep. Higher blood DHA was also associated with better sleep in the broader cohort.
In adults, a Norwegian study by Hansen and colleagues (2014) found that men eating fatty fish (Atlantic salmon) three times a week during the winter reported improvements in sleep latency and daily functioning compared with a control group eating chicken, pork or beef.
A randomized trial by Patan and colleagues (2021) in healthy young adults compared DHA-rich and EPA-rich oils with placebo. Interestingly, the DHA-rich oil showed some unfavorable effects on certain sleep measures, while the EPA-rich oil produced modest improvements in some subjective and objective parameters. This highlights that EPA and DHA may not act identically.
A systematic review and meta-analysis by Dai and Liu (2021) concluded that omega-3 intake may improve sleep quality in some populations, particularly infants and children, but evidence in adults was inconsistent and of limited quality.
| Population | Main finding | Confidence |
|---|---|---|
| Children | Better sleep with DHA in some trials | Low to moderate |
| Healthy adults | Mixed; effects may differ for EPA and DHA | Low |
| Fish eaters vs. non-fish eaters | Some improvement in sleep latency | Low |
| Athletes | Very limited direct data | Very low |
Relevance for athletes
Direct research on omega-3 and sleep in athletes is scarce. Most interest in omega-3 supplementation for sport, summarized by Philpott, Witard and Galloway (2019), focuses on muscle soreness, muscle protein synthesis, concussion and cardiovascular function rather than sleep.
That said, many athletes have low omega-3 status. Studies of college athletes in the US have reported low omega-3 index values, a measure of EPA and DHA in red blood cell membranes. Correcting low status is likely to be more beneficial than adding more on top of already adequate intake.
If omega-3s do improve sleep, the effect is probably modest and develops over weeks as fatty acids gradually integrate into cell membranes. It is unlikely to be noticed after a single dose, in contrast to substances such as melatonin.
Athletes looking for better sleep will usually benefit more from consistent sleep schedules, reduced evening light exposure, limiting caffeine after mid-afternoon and managing training load. Omega-3 is best seen as a supporting element within that broader routine.
Practical recommendations and safety
The Dietary Guidelines for Americans encourage about 8 ounces of seafood per week for adults, which provides roughly 250 mg per day of EPA and DHA on average. Fatty fish such as salmon, sardines, mackerel and trout are the richest sources.
For people who eat little fish, supplements providing about 500–1,000 mg of combined EPA and DHA per day are a common choice. Some sports studies have used 2–3 g per day. The FDA has indicated that up to 5 g per day of EPA and DHA from supplements is generally safe for adults.
- Take omega-3 with a meal containing fat to improve absorption and reduce fishy burps.
- Look for products that state EPA and DHA content per serving, not just total fish oil.
- Choose third-party tested products for purity and low oxidation.
- Algae oil is a suitable vegan source of DHA and EPA.
Higher doses can increase the risk of bleeding in people on anticoagulants, and a meta-analysis by Gencer and colleagues (2021) found a modestly increased risk of atrial fibrillation with omega-3 doses above 1 g per day in cardiovascular outcome trials. People with heart rhythm disorders or on blood thinners should consult a doctor first.
Conclusions of the editorial team
There are plausible mechanisms linking omega-3 fatty acids to sleep, and some studies, particularly in children and fish eaters, show modest improvements. Evidence in healthy adults and athletes remains inconsistent.
Omega-3 supplementation is reasonable for people with low fish intake for its broader health benefits, but it should not be expected to fix poor sleep on its own.
For more on recovery, we suggest our articles on magnesium and sleep, on caffeine timing for athletes, and on tart cherry juice as a recovery aid.
References
- Halson SL. Sleep in elite athletes and nutritional interventions to enhance sleep. Sports Med. 2014;44(Suppl 1):S13–S23.
- Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study—a randomized controlled trial. J Sleep Res. 2014;23(4):364–388.
- Hansen AL, Dahl L, Olson G, et al. Fish consumption, sleep, daily functioning, and heart rate variability. J Clin Sleep Med. 2014;10(5):567–575.
- Patan MJ, Kennedy DO, Husberg C, et al. Differential effects of DHA- and EPA-rich oils on sleep in healthy young adults: a randomized controlled trial. Nutrients. 2021;13(1):248.
- Dai Y, Liu J. Omega-3 long-chain polyunsaturated fatty acid and sleep: a systematic review and meta-analysis of randomized controlled trials and longitudinal studies. Nutr Rev. 2021;79(8):847–868.
- Philpott JD, Witard OC, Galloway SDR. Applications of omega-3 polyunsaturated fatty acid supplementation for sport performance. Res Sports Med. 2019;27(2):219–237.
- Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981–1990.
